Prospective follow-up in PIOPED was done to detect clinical events that could represent PE.' This PIOPED follow-up protocol detected only symptomatic events. After discharge from the hospital, each patient was contacted by telephone at 1, 3, 6, and 12 months. The reporting of rehospitalization, any new investigation for PE, or death led to a detailed review of the patient's medical records by the outcome classification committee. Diagnostic studies for PE during the period of follow-up were ordered by the attending physician on the basis of clinical suspicion and were not part of the study protocol. Pulmonary embolism during the period of follow-up was diagnosed on the basis of a clinical suspicion confirmed by an abnormal pulmonary angiogram, high-probability ventilation-perfusion lung scan, or autopsy.
Purpose: The purpose of this investigation was to determine the frequency of future pulmonary embolism (PE) among patients in whom PE was suspected and excluded by pulmonary angiography. Methods: Data are from the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED). The present investigation includes 380 patients in whom PE was excluded by pulmonary angiography and who received no anticoagulant therapy while in the hospital or after discharge. Patients were followed 1 
RESULTS
Among the 380 patients with normal pulmonary angiograms who received no anticoagulant therapy, the cumulative number of deaths from all causes at 1 month, 3 months, 6 months, 9 months, and 1 year was 35, 60, 75, 85, and 89, respectively. Only two deaths were related to PE, and both were in the first month. Four of the six (67%) episodes of PE were nonfatal. Three of six (50%) PE occurred in the first 8 days and four of six (67%) PE occurred within the first month (Table 1) . Among 380 patients with normal pulmonary angiograms, six (1.6%) (Cl, 0.3 to 2.9%) suffered clinical PE during the year of followup. Among 291 patients with normal pulmonary angiograms who survived the year of follow-up, nonfatal PE occurred in four (1.4%).
Regarding the two patients who died of PE, one patient, a 33-year-old woman, had underlying primary pulmonary hypertension with right ventricular failure (Tables 1 and 2 (Table 2) .
DISCUSSION
Pulmonary embolism during the year of follow-up of patients who had a normal pulmonary angiogram was uncommon in our experience (1.6%) and it was uncommon in the experience of others.4-6 Cheely and associates4 followed up 144 patients with normal pulmonary angiograms an average of 13 months. There were 32 deaths from unrelated illnesses. Nonfatal PE occurred in 3 of 112 (2.7%) survivors and PE was observed 3 of 11 patients in whom autopsies were performed. The total frequency of PE, therefore, was 6 of 144 (4.2%). Among 44 patients with normal pulmonary angiograms, Hull and associates5 observed one fatal PE (2.3%) that occurred in 2 weeks in a patient with untreated calf vein thrombosis.
Novelline and associates6 followed up 167 untreated patients with normal pulmonary angiograms a minimum of 6 Whether PE after a normal pulmonary angiogram represents a recurrent PE in patients in whom the prior PE could not be definitively diagnosed or whether the PE was the first PE in a patient with a prior normal pulmonary angiogram is uncertain. Many of the patients were at risk of PE and had clinical findings suggesting deep venous thrombosis.
Even though the frequency of PE was low during 1 year of follow-up of patients with a normal pulmonary angiogram, the frequency of PE in this group was higher than in the general population of hospitalized patients. During the 21-month period of recruitment for PIOPED, among patients in whom PE was diagnosed on the basis of the same criteria as used in the follow-up of patients in the PIOPED study, (a clinical suspicion confirmed by pulmonary angiography, a high-probability interpretation of the ventilation-perfusion lung scan, or confirmed at autopsy), PE was diagnosed in 0.3% (P.D.S. and J.W.H., May 1994, personal communication). Using the same criteria, Huber and associates8 reported an identical prevalence.
One or more objective leg tests suggestive of deep venous thrombosis was observed in 10%o of the patients who had such tests. This was comparable to the frequency of 18% observed by Hull and associates9 among patients with normal pulmonary angiograms. Patients with at least one test indicative of deep venous thrombosis, although such tests may have been inconsistent, showed PE on follow-up more frequently than patients with normal studies. A history of thrombophlebitis or an abnormal result of a leg test in 83% of patients who developed PE after a normal pulmonary angiogram suggests that deep venous thrombosis may have been present in these patients.
In conclusion, the frequency of clinically important PE developing within 1 year in patients with a normal pulmonary angiogram is small. Even so, the frequency was higher than is reported in the general population of hospitalized patients and probably could be reduced further by studies of the lower extremities for deep venous thrombosis. A cost-benefit analysis of this approach, however, has not been assessed.
